| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Oct 8, 2024 | Curia 在米兰的 CPHI WW 展会上推出其重塑品牌 | 奥尔巴尼，纽约州, Oct. 08, 2024 (GLOBE NEWSWIRE) -- 业内领先的合同研发生产组织 Curia 今日宣布推出其重塑品牌。 本次更新引入了精致的企业传播信息和全新品牌层级结构，突显了 Curia 广泛跻身小分子、仿制药活性药物成分和生物制剂领域的合同研发生产组织（CDMO）能力。 此次品牌更新深刻彰显了 Curia 作为客户忠实盟友的坚定立场。凭借逾 30 年的行业经验和强大的全球影响力，Curia 能够在药物发现、开发和制造领域妥善应对各种简单... |
| Oct 8, 2024 | Curia Commits to SBTi Net-Zero Standard | ALBANY, N.Y., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today announced its commitment to set near- and long-term company-wide greenhouse gas (GHG) emission reductions ... |
| Oct 7, 2024 | Curia Unveils Brand Refresh at CPHI WW in Milan | ALBANY, N.Y., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufacturing organization, today unveiled its refreshed brand. The update introduces refined corporate messaging and a new brand hierarchy,... |
| Oct 7, 2024 | Curia Unveils Brand Refresh at CPHI WW in Milan | The refined brand highlights Curia’s key capabilities and personalized approach across small molecules, generic APIs and biologics
ALBANY, N.Y., Oct. 07, 2024 (GLOBE NEWSWIRE) -- Curia, a leading contract research, development and manufactu... |
| Aug 14, 2024 | Navigating New Frontiers in Biotech and MedTech: Leadership Changes and Funding Triumphs | In the ever-evolving landscape of biotechnology and medical technology, two companies are making headlines. Bio X Cell and Prana Thoracic are not just names; they are symbols of innovation and ambition. Each company is carving its path, dri... |
| Aug 12, 2024 | Bio X Cell Announces CEO Appointment | A Leading Producer of Monoclonal Antibodies
LEBANON, N.H., Aug. 12, 2024 /PRNewswire/ -- Bio X Cell, LLC ("BXC" or the "Company"), a leading producer of monoclonal antibodies for pre-clinical in vivo research application... |
| May 15, 2023 | Fast-Tracking Drug Development and Scale-Up in the Post-Covid World, Upcoming Webinar Hosted by Xtalks | Join this webinar to learn how to accelerate drug development timelines in the post-Covid era.
TORONTO, Ontario, Canada (PRWEB) May 15, 2023
Curia’s Approach to Rapid Scale up and Development
The webinar will focus on truncating drug develo... |
| Apr 10, 2023 | A Customized Approach to mRNA Manufacturing, Upcoming Webinar Hosted by Xtalks | Using literature and experimental design, adapting each method to fit the molecule is necessary for hastening the optimization of development.
TORONTO (PRWEB) April 10, 2023
Diversity in mRNA therapies has mitigated advancements in the proc... |
| Dec 1, 2022 | T3P – A Versatile Peptide Coupling and Water Removal Reagent, Offering Several Process Advantages, Upcoming Webinar Hosted by Xtalks | The reagent may readily be used for various other functional group transformation reactions including nitrile formation from carboxamides, alcohol oxidation (Swern-type oxidation), ester formation, Lossen rearrangement, Beckmann rearrangeme... |
| Nov 30, 2022 | Building Efficiency into Biologics Formulations Development, Upcoming Webinar Hosted by Xtalks | Formulation development can be met with many challenges as biologics are often sensitive molecules with a variety of competing degradation possibilities.
TORONTO (PRWEB) November 30, 2022
Complex macromolecules are becoming a mainstay of ph... |
| Oct 27, 2022 | Curia Celebrates Ground-breaking Ceremony in Albuquerque | Construction begins on sterile fill-finish expansion for the production of vaccines and injectable medicines
ALBANY, N.Y. & ALBUQUERQUE, N.M.–(BUSINESS WIRE)–October 27, 2022–
Curia, a leading contract research, development and manufact... |
| Aug 2, 2022 | Curia Appoints Niall Condon to Lead Manufacturing | ALBANY, N.Y.–(BUSINESS WIRE)–August 2, 2022–
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced the appointment of Niall Condon as president of its Manufacturing Division, with imm... |
| Jun 9, 2022 | Curia and Replicate Bioscience Enter Strategic Collaboration to Create Groundbreaking Development Platform for Self-Replicating RNA (srRNA) | ALBANY, N.Y.–(BUSINESS WIRE)–June 9, 2022–
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, and Replicate Bioscience, a company pioneering ways to prevent drug resistance in cancer and to treat ... |
| Jun 9, 2022 | Curia and Replicate Bioscience Enter Strategic Collaboration to Create Groundbreaking Development Platform for Self-Replicating RNA (srRNA) | ALBANY, N.Y.--(BUSINESS WIRE)--Curia, formerly AMRI, a leading contract research, development and manufacturing organization, and Replicate Bioscience, a company pioneering ways to prevent drug resistance in cancer and to treat autoimmune a... |
| Jun 6, 2022 | Curia Adopts the Berkeley Lights Platform to Expand its Antibody Discovery Capabilities | EMERYVILLE, Calif. & ALBANY, N.Y.–(BUSINESS WIRE)–June 6, 2022–
Berkeley Lights, Inc. (Nasdaq: BLI), a leader in digital cell biology, and Curia, formerly AMRI, a leading contract research, development and manufacturing organization (CD... |
| Mar 9, 2022 | Curia Enters Cooperative Agreement with U.S. Government to Expand Sterile Fill-Finish Capability | Additional High-Speed Line Adds BSL2 Capacity in the U.S.
ALBANY, N.Y.–(BUSINESS WIRE)–March 9, 2022–
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced a cooperative agreement wit... |
| Feb 14, 2022 | Integrity Bio and LakePharma Become Curia | Companies Unite Under One Brand to Provide Seamless, Comprehensive Biologics Discovery, Development and Manufacturing Solutions
ALBANY, N.Y.–(BUSINESS WIRE)–February 14, 2022–
Curia, formerly AMRI, a leading contract research, development a... |
| Feb 8, 2022 | Development, Manufacturing, and Characterization of mRNA-based Therapeutics, Upcoming Webinar Hosted by Xtalks | The power of the technology was demonstrated with the rapid development of COVID-19 vaccines and it has the potential to treat previously intractable diseases.
TORONTO (PRWEB) February 08, 2022
The advent of mRNA-based vaccines and therapeu... |
| Dec 22, 2021 | Curia Unveils Comprehensive mRNA Solution | Curia’s mRNA Services Combine Comprehensive Experience and Flexible Capabilities from Discovery Through Fill-Finish Manufacturing
ALBANY, N.Y.–(BUSINESS WIRE)–December 22, 2021–
Curia, formerly AMRI, a leading contract research, development... |
| Oct 6, 2021 | Strategies for Phenotypic Drug Discovery Programs Using High-Content Imaging, Upcoming Webinar Hosted by Xtalks | Recent advantages in automation, miniaturization, imaging and analysis have dramatically increased the size of libraries and complexity of disease states which can be examined.
TORONTO (PRWEB) October 06, 2021
Phenotypic screening has becom... |
| Sep 2, 2021 | Curia Completes Acquisition of LakePharma | Adds biologics development capabilities, expertise and scale from discovery through GMP manufacturing
ALBANY, N.Y.–(BUSINESS WIRE)–September 2, 2021–
Curia, formerly AMRI, a leading contract research, development and manufacturing organizat... |
| Aug 19, 2021 | Curia to Expand U.S. Commercial Manufacturing Capability | ALBANY, N.Y.–(BUSINESS WIRE)–August 19, 2021–
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced plans to expand its commercial manufacturing capacity at its Rensselaer, New York f... |
| Aug 4, 2021 | Curia Completes Acquisition of Integrity Bio | All the sessions from Transform 2021 are available on-demand now. Watch now.
Transaction adds biologic capabilities and expands capacity
ALBANY, N.Y.–(BUSINESS WIRE)–August 4, 2021–
Curia, formerly AMRI, a leading contract research, develop... |
| Aug 4, 2021 | Curia Completes Acquisition of Integrity Bio | Transaction adds biologic capabilities and expands capacity
ALBANY, N.Y.–(BUSINESS WIRE)–August 4, 2021–
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announced it has completed the tra... |
| Jul 14, 2021 | Curia to Acquire US-Based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics | Join executive leaders at the Conversational AI & Intelligent AI Assistants Summit, presented by Five9. Watch now!
Adds integrated biologics development platform from discovery through GMP manufacturing
ALBANY, N.Y.–(BUSINESS WIRE)–July... |
| Jul 14, 2021 | Curia to Acquire US-Based LakePharma, Expanding End-to-End R&D Capabilities and Scale for Biologics | Adds integrated biologics development platform from discovery through GMP manufacturing
ALBANY, N.Y.–(BUSINESS WIRE)–July 14, 2021–
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today announc... |
| Jul 13, 2021 | Curia to Acquire Integrity Bio, Expanding Biologic Formulation and Fill-Finish Capabilities | Adds to Drug Product Aseptic Formulation Development Expertise and Drug Product Manufacturing
ALBANY, N.Y.–(BUSINESS WIRE)–July 13, 2021–
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, today a... |
| Jul 13, 2021 | Curia to Acquire Integrity Bio, Expanding Biologic Formulation and Fill-Finish Capabilities | Join executive leaders at the Data, Analytics, & Intelligent Automation Summit, presented by Accenture. Watch now!
Adds to Drug Product Aseptic Formulation Development Expertise and Drug Product Manufacturing
ALBANY, N.Y.–(BUSINESS WIRE... |
| Jul 11, 2021 | AMRI Becomes Curia | New Brand Reinforces Commitment to Ongoing Expansion of Expertise, Capabilities and Contributions to Health Care
ALBANY, N.Y.–(BUSINESS WIRE)–July 12, 2021–
Albany Molecular Research, Inc. (AMRI), a leading global contract research, develop... |
| Jul 11, 2021 | AMRI Becomes Curia | Join AI & data leaders at Transform 2021 on July 12th for the AI/ML Automation Technology Summit. Register today.
New Brand Reinforces Commitment to Ongoing Expansion of Expertise, Capabilities and Contributions to Health Care
ALBANY, N... |
